While Australia grapples with its challenges in ensuring access to the cures listed on the PBS for almost ten years, with one-third of patients still untreated, the US Department of Health and Human Services has announced a US$100 million pilot program.
Substantial US program aims to address gaps in Hepatitis C diagnosis and cure
July 31, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Trump administration takes another step in 'Most Favored Nation' push
August 1, 2025 - - Latest News -
Arrotex expands haematology-oncology portfolio through Antengene partnership
August 1, 2025 - - Latest News -
Study reveals growing benefit of Lilly therapy for early symptomatic Alzheimer’s disease
August 1, 2025 - - Latest News -
Novartis backs the launch of a new cardiovascular disease program
August 1, 2025 - - Latest News -
New pharmacy-focused partnership marks the launch of two first-to-market biosimilars
August 1, 2025 - - Latest News -
AusBiotech and Medicines Australia celebrate Catalyst outcomes and further strengthen industry collaboration
August 1, 2025 - - Latest News -
AbbVie therapy now available on the PBS for treatment of advanced Parkinson’s
August 1, 2025 - - Latest News